Refractory pruritus in end-stage prostatic adenocarcinoma: an unusual presentation of a hypereosinophilic syndrome
European Journal of Case Reports in Internal Medicine · 17.07.2026 · 13 (8)
DOI: 10.12890/2026_007237 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Case Reports in Internal Medicine, online erschienen am 17.07.2026. Verfasst von Luca Lorusso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Palliative and Supportive Care Clinic, Ente Ospedaliero Cantonale, Bellinzona, Switzerland. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Hypereosinophilic syndrome (HES) associated with advanced adenocarcinoma of the prostate is an exceptionally rare paraneoplastic condition. Available evidence suggests that eosinophilia may correlate with tumour progression and poor prognosis. Cutaneous manifestations, including severe pruritus and angioedaema, may significantly impair quality of life and represent particularly challenging symptoms in a palliative care setting. Pruritus management requires individualised multidisciplinary approaches including corticosteroids, antihistamines, gabapentinoids, antidepressants, opioid modulation and supportive care measures. In refractory cases, severe pruritus associated with HES may become a source of profound suffering and in end-of-life care may require palliative sedation to relieve otherwise intolerable distress. Case description: We report the case of a patient with prostatic acinar adenocarcinoma who developed paraneoplastic HES, presenting with severe refractory pruritus and recurrent angioedaema. Despite multiple symptomatic treatments, the patient experienced progressive symptom burden with significant impairment in quality of life, ultimately requiring terminal palliative sedation during end-of-life care.
Conclusion
This case highlights the diagnostic challenges of HES, the importance of malignancy progression and the severe impact of uncontrolled eosinophil-mediated symptoms in advanced cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Palliative and Supportive Care Clinic, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
- Department of Internal Medicine, Ospedale Regionale di Lugano, Ente Ospedaliero Cantonale, Lugano, Switzerland.
- Faculty of Medicine, University of Geneva, Switzerland.
- Department of Rehabilitation and Geriatrics, University of Geneva, Switzerland.
Zitieren
APA
Lorusso, L., Bovello, M. V., Cavagna, M., Mare, M., Caimi, C., & Fusi-Schmidhauser, T. (2026). Refractory pruritus in end-stage prostatic adenocarcinoma: an unusual presentation of a hypereosinophilic syndrome. European Journal of Case Reports in Internal Medicine, 13(8). https://doi.org/10.12890/2026_007237
Vancouver
Lorusso L, Bovello MV, Cavagna M, Mare M, Caimi C, Fusi-Schmidhauser T. Refractory pruritus in end-stage prostatic adenocarcinoma: an unusual presentation of a hypereosinophilic syndrome. European Journal of Case Reports in Internal Medicine. 2026;13(8). doi:10.12890/2026_007237
BibTeX
@article{Lorusso2026,
author = {Lorusso, Luca and Bovello, Manuel Vittorio and Cavagna, Mattia and Mare, Micaela and Caimi, Clarissa and Fusi-Schmidhauser, Tanja},
title = {Refractory pruritus in end-stage prostatic adenocarcinoma: an unusual presentation of a hypereosinophilic syndrome},
journal = {European Journal of Case Reports in Internal Medicine},
year = {2026},
volume = {13},
number = {8},
doi = {10.12890/2026_007237}
}
EUVIMED